neurodegenerative diseases - search results

Jason Tait Sanchez provides insight into why the genetically modified chicken is a sound approach to the study of hearing

Open Access Government looks at the wider work of The National Institute of Neurological Disorders and Stroke in the U.S. when it comes to reducing the burden of neurological disease and how they are supporting stroke research

David Bearman, M.D., Executive VP of the American Academy of Cannabinoid Medicine details the research priorities for cannabis, one of the most thoroughly studied plants of all time 

Boris Šustaršič, President of the European Alliance of Neuromuscular Disorders Associations shares his thoughts on the key issues around muscular dystrophy (MD) in Europe today 

Shyh-Jye Lee (Jeff), Ph. D, President of the Taiwanese Society of Developmental Biology (TSDB) explains the way in which developmental biology impacts upon our lives

Professor Tanese of the New York University School of Medicine discusses Huntington’s disease Mutation in the huntingtin gene causes Huntington’s disease, a heritable and fatal neurodegenerative disease. The production of mutant huntingtin (HTT) protein is thought to be responsible for alterations of normal processes that ultimately result in the death of neurons....

A new study published in the Movement Disorders journal, has paved the way for more research into identifying markers of progression for patients in the early stages of Parkinson’s disease

Sorcha McPhillips, Chief Executive of the Huntington’s disease (HD) Association for Northern Ireland, raises awareness of HD and discusses the impact of hope on the community in the face of new treatments

Andreas Prokop from the British Society for Developmental Biology explores how developmental biology (DB) addresses questions of societal importance The life science discipline Developmental Biology (DB) aims to understand the processes that lead from the fertilisation of an egg cell (or equivalent) to the formation of a well-structured and functional...

Prof. David Dexter, deputy director of research at Parkinson’s UK shares his thoughts on the symptoms of Parkinson’s and the chances of finding a cure

Experts from the European Laboratory for Non-Linear Spectroscopy and the Neuroscience Institute reflect on cerebral blood flow (CBF)

A man in a vegetative state in France has regained a degree of consciousness after experimental therapy of placing a nerve stimulator on his chest After being in a vegetative state for 15 years, the unnamed 35-year-old patient responded to nerve stimulator therapy and within a month was able to...

Prof Michael R Hamblin of the Wellman Center for Photomedicine at Massachusetts General Hospital discusses a new light-based therapy for Alzheimer’s disease

Ai-Ling Lin of the Lin Brain Lab details how neuroimaging research can be used to reduce brain aging and the impact of Alzheimer’s disease

The changing pharma landscape means opportunities for Parkinson's drug discovery are missed, but Parkinson's UK has a new strategy to redress the balance This will be the 200th year since James Parkinson wrote his seminal paper on ‘the Shaking Palsy’. Since that time there have been major developments in the...

Dr Ramón Cacabelos, President of EuroEspes Biomedical Research Center, highlights the potential benefits of novel nutraceuticals including ProteoLipins Pharmacotherapy is a fundamental cornerstone in the global fight against disease worldwide. The value of drug production has grown four times more rapidly than the world’s income. High-income countries dominate in world...

Sumith A Kularatne, Vice President of Research and Development at On Target Laboratories shares the research strides he has made in drug development

Peter F. Kador, Ph.D., FARVO, College of Pharmacy, University of Nebraska and President and CEO, Therapeutic Vision, Inc. discusses antioxidant therapies.

Background of Alzheimer’s disease Alzheimer’s disease (AD) is one of the most devastating neurodegenerative disorders affecting more than 25 million people worldwide which is the fifth leading cause of death for those aged 65 years and above. The disease typically starts with a difficulty to remember new information and as...

The Nanobiotechnology for Diagnostics (Nb4D) Group belongs to the Institute of Advanced Chemistry of Catalonia (IQAC), one of the institutes of the State Agency CSIC (Consejo Superior de Investigaciones Científicas), and to the Biomedical Research Centre Network of Bioengineering, Biomaterials and Nanomedicine (CIBERBBN). The group is led by Prof. M.-Pilar...